{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:03:29Z","timestamp":1767337409044,"version":"3.38.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.ejphar.2010.11.036","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T09:16:20Z","timestamp":1293009380000},"page":"86-91","source":"Crossref","is-referenced-by-count":29,"title":["Lack of evidence that nebivolol is a \u03b23-adrenoceptor agonist"],"prefix":"10.1016","volume":"654","author":[{"given":"Elfaridah P.","family":"Frazier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina B.","family":"Michel-Reher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"van Loenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Sand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan L.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.11.036_bb0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","article-title":"The selectivity of \u03b2-adrenoceptor agonists at human \u03b21-, \u03b22- and \u03b23-adrenoceptors","volume":"160","author":"Baker","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.CIR.102.6.677","article-title":"Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial \u03b22-adrenergic receptor-mediated nitric oxide production","volume":"102","author":"Broeders","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.11.036_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(02)02875-3","article-title":"\u03b21-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies","volume":"460","author":"Bundkirchen","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(24)34946-8","article-title":"Potent and selective human \u03b23-adrenergic receptor antagonists","volume":"290","author":"Candelore","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0030","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0035","first-page":"615","article-title":"NO-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by \u03b2-adrenoceptors or by 5 HT1A-receptors","volume":"55","author":"Chlopicki","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00005344-200308000-00012","article-title":"Involvement of the \u03b23 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta","volume":"42","author":"de Groot","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0045","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial \u03b23-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.11.036_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2006.12.008","article-title":"Effect of dl-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells","volume":"55","author":"Evangelista","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00210-006-0065-2","article-title":"\u03b2-Adrenoceptors and potassium channels","volume":"373","author":"Ferro","year":"2006","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.104.077768","article-title":"Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?","volume":"313","author":"Frazier","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00210-006-0077-y","article-title":"Effects of gender, age and hypertension on \u03b2-adrenergic receptor function in rat urinary bladder","volume":"373","author":"Frazier","year":"2006","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00210-007-0208-0","article-title":"Signal transduction underlying control of urinary bladder smooth muscle tone by muscarinic receptors and \u03b2-adrenoceptors","volume":"377","author":"Frazier","year":"2008","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00005344-200405000-00005","article-title":"Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation","volume":"43","author":"Garban","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","article-title":"Comparative pharmacology of human \u03b2-adrenergic receptor subtypes \u2014 characterization of stably transfected receptors in CHO cells","volume":"369","author":"Hoffmann","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.2008.00044.x","article-title":"Different pharmacological properties of two enantiomers in a unique \u03b2-blocker, nebivolol","volume":"26","author":"Ignarro","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0090","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000066912.58385.DE","article-title":"Third-generation \u03b2-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action","volume":"107","author":"Kalinowski","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.11.036_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11530710-000000000-00000","article-title":"Nebivolol. Haemodynamic effects clinical significance combined \u03b2 blockade nitric oxide release","volume":"70","author":"Kamp","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2010.11.036_bb0100","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0024-3205(01)01488-6","article-title":"Functional muscarinic M2 and M3 receptors and \u03b2-adrenoceptors in cultured rat bladder smooth muscle","volume":"70","author":"Ma","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/mol.107.040923","article-title":"Ligand-directed signaling: 50 ways to find a lover","volume":"72","author":"Michel","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00345-009-0416-y","article-title":"Effect of pre-contraction on \u03b2-adrenoceptor-mediated relaxation of rat urinary bladder","volume":"27","author":"Michel","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0115","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","article-title":"\u03b11-, \u03b12- and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00210-006-0104-z","article-title":"Comparison of three radioligands for the labelling of human \u03b2-adrenoceptor subtypes","volume":"374","author":"Niclau\u00df","year":"2006","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0026-895X(25)10118-1","article-title":"The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various \u03b2-adrenergic blockers","volume":"34","author":"Pauwels","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.pharmthera.2005.12.002","article-title":"\u03b23-Adrenoceptors in the cardiovascular system: putative roles in human pathologies","volume":"111","author":"Rozec","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjp.0706648","article-title":"Mixed \u03b23-adrenoceptor agonist and \u03b11-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta","volume":"147","author":"Rozec","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0140","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2008.11.057","article-title":"Nebivolol, a vasodilating selective \u03b21-blocker is a \u03b23-adrenoceptor agonist in the nonfailing transplanted heart","volume":"53","author":"Rozec","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1124\/mol.107.035337","article-title":"Ligand-directed signaling at the \u03b23-adrenoceptor produced by SR59230A relative to receptor agonists","volume":"74","author":"Sato","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00210-007-0167-5","article-title":"Activation of inwardly rectifying Kir2.x potassium channels by \u03b23-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2","volume":"375","author":"Scherer","year":"2007","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00500826","article-title":"Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex","volume":"311","author":"Schlicker","year":"1985","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.2009.00074.x","article-title":"Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta","volume":"156","author":"Tran Quang","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1007760515117","article-title":"Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure","volume":"12","author":"van Nueten","year":"1998","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-006-0127-5","article-title":"Tools to study \u03b23-adrenoceptors","volume":"374","author":"Vrydag","year":"2007","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20420","article-title":"\u03b23-Adrenoceptors in urinary bladder","volume":"26","author":"Yamaguchi","year":"2007","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2010.11.036_bb0180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/nau.20231","article-title":"Effects of 138-355, a \u03b23-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro","volume":"25","author":"Yamanishi","year":"2006","journal-title":"Neurourol. Urodyn."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910012082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910012082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:58:38Z","timestamp":1740790718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910012082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0014299910012082"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.11.036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}